Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03530254 · ClinicalTrials.gov registry record · NA
Clinical Study of PGT-A Versus PGT-A+ERA
A NA study, sponsored by Igenomix.
- Terminated
- Registry status
- NA
- Development phase
- 368
- Enrollment target
NCT03530254: Clinical Trial NA study, sponsored by Igenomix.
NCT03530254 is a NA study that was terminated before completion, run by Igenomix. The registered enrollment target is 368 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03530254, a NA study, was terminated before completion, sponsored by Igenomix.
- TERMINATED
- Registry status
- NA
- Development phase
- 368 participants
- Enrollment target
Study Summary
Patients who have shown previous implantation failures, despite transferring good quality and chromosomally normal embryos (diagnosed by PGT-A), could have a displaced Window of Implantation (WOI) and consequently, alterations in their endometrial receptivity. The correction of this displacement can improve the results of the Assisted Reproduction Treatments (ART). The ERA test (Endometrial Receptivity Analysis) evaluates the transcriptomic endometrial profile to determine if the patient's uterus is receptive when the embryo is transferred during an In Vitro Fertilization (IVF) process, and identifies the personalized WOI of the patient. This process is called Personalized Embryo Transfer (pET). The Preimplantation Genetic Test of Aneuploidies or PGT-A (Preimplantation Genetic Testing for Aneuploidy), is currently carried out using Next Generation Sequencing (NGS) and serves to identify chromosomally normal embryos prior to their transfer in an IVF treatment. Aneuploidies are rarely compatible with life or can cause congenital diseases. So, the identification of chromosomally normal embryos, improves the success of reproduction in cases in which infertility is caused by such aneuploidies. Therefore, the aim of this study is to determine, in a randomized and prospective way, the clinical benefit of adding the ERA test to the embryonic aneuploidies test for patients with a PGT-A indication.
Primary Outcome
Number of babies born per embryo transfer
Interventions
- DIAGNOSTIC_TEST PGT-A
- DIAGNOSTIC_TEST ERA Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2018-05-28 |
| Est. Completion | 2022-02-22 |
| Phase | NA |
Why NCT03530254 stopped before completion
NCT03530254 is an interventional study that assigns participants to a tested intervention. The registered 368 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which PGT-A is the first listed.
NCT03530254 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03530254 about?
NCT03530254 is a clinical study titled "Clinical Study of PGT-A Versus PGT-A+ERA". Patients who have shown previous implantation failures, despite transferring good quality and chromosomally normal embryos (diagnosed by PGT-A), could have a displaced Window of Implantation (WOI) and consequently, alterations in their endometrial receptivity. The correction of this displacement can...
What is the current status of trial NCT03530254?
This trial is currently terminated. It is a NA study. The enrollment target is 368 participants. The study started on 2018-05-28. Estimated completion is 2022-02-22.
What interventions are being tested in trial NCT03530254?
The interventions under investigation include: PGT-A (DIAGNOSTIC_TEST), ERA Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03530254?
This trial is sponsored by Igenomix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03530254's enrollment target sits among peer trials
368 283rd of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI